CD133+ Cell Therapy for Refractory Coronary Heart Disease

NCT01049867 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

PROCEDURE: Intracoronary Infusion of CD133+ Cells

Sponsor

Hospital y Clinica OCA, S.A. de C.V.